In a quietly published news release June 29, 2022, the US Department of Health and Human Services announced that it, in partnership with the Department of Defense, has agreed to purchase an additional 105 million shots of COVID-19 by Pfizer – for $3.2 billion.first
The contract is intended to provide injections for an injection campaign this coming fall and includes options to purchase up to 300 million doses. The decision came after the June 28, 2022 meeting of the U.S. Food and Drug Administration (VRBPAC) Vaccine and Related Biological Products Advisory Committee, which recommended that the specific ingredient Omicron should be included in the COVID-19 booster shot in the United States.2
“We look forward to providing vaccines specifically for this new variant and working with state and local health departments, pharmacies, healthcare providers, qualified federal health centers and other partners to make them available to communities across the country this fall.” Dawn O’Connell, HHS assistant secretary for preparedness and response, said in the press release.3
More Billions of Dollars Go to Failed Injections
The shots, which include both adult and pediatric doses, averaged more than $30 per dose, up more than 50% from the $19.50 per dose in the original US government contract with the US government. Pfizer.4 Some adult doses are now packaged in single-dose vials, which are more expensive to manufacture but are intended to reduce the waste that often occurs from opened multi-dose vials.
Pfizer makes a significant profit from the contract and has forecast that its COVID-19 gun sales will reach $32 billion by 2022.5 It is the American public that will lose on this deal, as they are inundated with a renewed attempt to get another shot of COVID-19, despite their continued setbacks.
Current COVID-19 booster shots lose effectiveness rapidly, with protection dropping sharply by the fourth month after injection.6 The eye-enhancement data, presented by the US Centers for Disease Control and Prevention, follow the same dismal effectiveness pattern shown by the primary COVID-19 mRNA shot, whose efficacy is also will decrease after a few months.
More insults to injury, study conducted by New York State Department of Health7 analyzed the results of 852,384 children aged 12 to 17 years and 365,502 children aged 5 to 11 years, who received two doses, between December 13, 2021 and January 24, 2022.
Children between the ages of 5 and 11 fell sharply again, dropping from 68% to just 12%. The rate of protection against hospitalization also decreased from 100% to 48%. In 11-year-olds alone, the vaccine’s effectiveness dropped to 11%.8 The lackluster response was attributed to differences in dosage between age groups, as children aged 5 to 11 years received two injections of Pfizer 10 micrograms, while children aged 12 to 17 years received 30 micrograms.9
The console acts like a ‘Crystal Ball’ in guessing which booster to use
It is well known that the protein mutates rapidly, essentially destroying almost any protection that COVID-19 shots provide soon after they are given. The end result is a seemingly never-ending series of annual shoots and boosters.
Pfizer claims that their new boost candidates will perform better than their previous versions. One option is considered to target only the Omicron variant, while the other option targets the strain in the original image along with the Omicron variation.ten Two doses – one consisting of 30 mcg of mRNA and one consisting of 60 mcg – were also tested, despite previous safety concerns with higher doses.11
While Pfizer cites strong antibody responses from refitted boosters, booster injection studies do not reveal whether the shots prevent COVID-19 cases or if they are effective. fruit for how long.twelfth VRBPAC voted 19-2 in favor of recommending Omicron-specific booster shots, but the FDA will ultimately decide which formulation will be in the “winning” injection.
Under discussion is whether the photographs should target the original Omicron strain BA.1 or the already emerging secondary variables – known as BA.4 and BA.5, which appear to be spreading in the US.13
Well-known pro-vaccine advocate Dr Paul Offit was one of two who voted against the booster recommendation, as he disagreed with the variant included and believed there was a “shortage of data” data” relates to the extent to which the body’s immune response to the antibody corresponds to acoustic protection.14
“I am still not comfortable enough that we have the information we need to fundamentally support this new product,” Offit said.15 The move highlights the uncertainty and conjecture surrounding the enhanced rollout. Committee member Adam Berger, of the US National Institutes of Health, also stated, “I’m not sure we have enough evidence to support a change today,” but he dropped it anyway. votes in favor of this recommendation.16 NBC News also reported:17
“Dr. Peter Marks, the FDA’s top vaccine regulator, acknowledged that the question before the committee is challenging and requires guesswork, saying the federal agency is essentially asking the committee to act as a kind of ‘crystal ball.’
… Committee member, Dr. Cody Meissner, a pediatrician at Tufts University School of Medicine, proposed that there was initially only a dual-value vaccine for adults, noting that scientists did not know. What are the potential side effects, if any, from multiple doses of the Covid vaccine. “
FDA’s ‘Future Framework’ Will Disappear With COVID Shot Tests
The FDA provided the agenda for the VRBPAC committee meeting,18 together with an 18-page abstract containing only 19 references, none of which were peer-reviewed.19 Political economist Toby Rogers wrote, “To base the entire future of COVID-19 shots on this glorified college semester paper is folly,” political economist Toby Rogers wrote. wrote, who explained that a “Future Framework” is being presented to exempt future COVID-19 scans from clinical trials:20
The summary document states: “The evaluation of a modified vaccine for the purpose of determining vaccine strain composition will need to be based primarily on comparative immunogenicity data due to the time constraints involved. to vaccine production and clinical efficacy evaluation. “
Have you caught that yet? The assessment “will need to rely on” (no decision is made here) measures that differ from actual health outcomes because of “time constraints”. Ah, $cience! Moderna, Pfizer, and Novavax are all developing reformatted COVID-19 shots. But they know that the FDA won’t review health outcomes so it will take a long time for them to trigger an antibody response.
… But VRBPAC admitted on April 6 that there is no known protective correlation (ie: antibody levels don’t tell you who will be immune) so antibody measures This is medically meaningless.
The Sane people realized that if you speed up the charging of the immune response, you can also speed up the charging of adverse events. But the “Future Framework” allows pharmaceutical companies to completely skip clinical trials.”
Furthermore, Rogers revealed that indeed the World Health Organization and Bill Gates are behind this effort to launch new COVID-19 vaccine formulations without adequate clinical trials. “This whole ‘Future Framework’ really comes from WHO. The Bill & Melinda Gates Foundation is the largest voluntary contributor to WHO.
So Gates has the potential to direct the play,” he explained, noting that WHO’s Kanta Subbarao – who previously worked at Fauci’s National Institute of Allergy and Infectious Diseases for 14 years – presented at the VRBPAC meeting on the topic “Consideration for vaccine strain composition from WHO CO-VAC TRIAL” [Technical Advisory Group on COVID-19 Vaccine Composition]. “
VRBPAC shoot approval would ‘increase harm to US public’
The gist of her presentation was that strain selection for COVID-19 shots must be coordinated globally similar to what happens for the flu. Brian Hooker, PhD, Scientific Director of Child Health Defense and a professor of biology at Simpson University, said: “Shoot the alarm bells about the needed VRBPAC approval of a future framework. with a move to recommend new COVID-19 booster shots for the fall. Guard:21
“The proposed move by VRBPAC would increase harm to the US public to unprecedented levels, as this action would further disrupt the necessary clinical trials, even beyond serious testing. important for the COVID-19 vaccine under the Emergency Use Authorization. This adds to the deceptive background used to license the original COVID-19 vaccine that was nowhere near proper testing.”
VRBPAC also has a history of allowing members with conflicts of interest to vote. When VRBPAC voted to allow COVID-19 injections for children under 6 months of age, Dr James Hildreth, who was exempted from the meeting, claimed a number of financial benefits associated with the trials. clinical trials of pediatric COVID-19 shots. are voted on, both personally and in relation to their employer.
Despite the contradictions, he was still allowed to vote at the session, voting favorably for all three pediatric COVID-19 shots.22
Millions of COVID-19 doses are wasted in the US
The US continues to stockpile COVID-19 shots, wasting billions of dollars on shots even as demand declines. An ABC News investigation found that millions of injections went unused as demand for injections plummeted. In speaking to health department officials in all 50 states, they found that millions of COVID-19 shots will be wasted, unused, or about to expire in the coming weeks. This includes:23
- 1.7 million doses wasted in Michigan as of December 2020
- 619,000 unused doses in Colorado
- 3.6 million photos are in storage in California
- Nearly 760,000 doses are considered non-viable, spoiled, or expired in Oregon
- Over 850,000 doses wasted in Wisconsin24
As people continue to realize that COVID-19 scans fail and the side effects can be serious – even deadly.25 – Increased reluctance to take pictures. In May 2022, only 18% of parents said they would be willing to give their under-5 child a COVID-19 shot, while 27% said they “definitely wouldn’t” give their child a shot.26
Such caution is wise, as the artificially raised antibodies from booster shots signal to your body that you are always infected and that the resulting immune response will come at a cost and can be detrimental to your health. your health, potentially accelerating the development of autoimmune disease. diseases such as Parkinson’s disease, Kawasaki disease, and multiple sclerosis.27
Furthermore, training your body to produce single antibodies to a mutated protein cannot compare to the protection provided by natural immunity, which occurs after recovering from illness. . According to Dr. Michael Yeadon, former vice president and chief scientific advisor of Pfizer, the human body has the best immune responses after a natural infection with COVID-19, not from exposure to a sudden protein. variable in injections.
He claims that 90% of the immune response that is mounted after natural exposure to COVID-19 is not at all to the mutant protein,28 raised concerns about the effectiveness of COVID-19 shots. However, the US government is moving forward with more shots. You can expect a fresh boost to boosters soon on the air, as HHS is expected to deliver its first latest COVID-19 shots in early fall.29
